Filter
91
Filtered Results: 91
Text search:
reporting
ADRs
Featured
Recommendations
10
New Publications
38
Language
Document type
No document type
57
Guidelines
14
Studies & Reports
11
Manuals
2
Strategic & Response Plan
2
Fact sheets
2
Training Material
1
Brochures
1
Situation Updates
1
Countries / Regions
Ethiopia
8
Kenya
7
Uganda
5
Philippines
5
Nigeria
4
India
4
Sierra Leone
3
Ghana
3
Nepal
3
South Africa
3
Malawi
3
Namibia
3
Rwanda
2
Indonesia
2
Bangladesh
2
Botswana
2
Lesotho
2
Liberia
1
Zimbabwe
1
Zambia
1
Tanzania
1
Cambodia
1
Thailand
1
Gambia
1
South–East Asia Region
1
Western and Central Europe
1
Asia
1
Eastern Europe
1
Georgia
1
Global
1
Authors & Publishers
Publication Years
Category
Countries
61
Public Health
2
Capacity Building
1
Key Resources
1
Pharmacy & Technologies
1
Toolboxes
Pharmacy
18
TB
13
AMR
3
HIV
2
Mental Health
2
COVID-19
2
NTDs
2
Polio
1
Caregiver
1
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o...
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effec...
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin...
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
(updated December 2014).
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve ... of adverse events (AEs) by strengthening passive safety
surveillance via PV training and mentoring of local PV stakeholders and healthcare providers (HCPs) at their own healthcare
facilities (HCFs).
Methods An 18-month PV training and mentoring programme was implemented in collaboration with national stakeholders,
and in partnership with the Ministry of Health, GSK and PATH. Two-day training was provided to Expanded Programme on
Immunisation coordinators, identified as responsible for AE reporting, and four National Regulatory Authority representa-
tives. Abridged PV training and mentoring were provided regularly to HCPs. Support was given in upgrading the national
PV system. Key performance indicators included the number of AEs reported, transmission of AE forms, completeness of
reports, serious AEs reported and timeliness of recording into VigiFlow.
Results In 18 months, 443 HCPs at 61 HCFs were trained. The number of reported AEs increased from 22 (January 2000 to
October 2016) to 228 (November 2016 to May 2018), enabling Malawi to become a member of the World Health Organization
Programme for International Drug Monitoring. Most (98%) AE report forms contained mandatory information on reporter,
event, patient and product, but under 1% were transmitted to the national PV office within 48 h.
Conclusion Regular PV training and mentoring of HCPs were effective in enhancing passive safety surveillance in Malawi,
but the transmission of reports to the national PV centre requires further improvement.
Some of the key findings of the report include:
Almost 80% of the general public are concerned about developing dementia at some point and 1 in 4 people think that there is nothing we can do to prevent dementia
35% of carers across the world said that they have hidden the diagnosis of de...
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica...
DRUGS REGULATORY UNIT | NOVEMBER 2009 | SECOND EDITION
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
Accessed November, 2017
